The selective hypoxia inducible factor-1 inhibitor PX-478...

Molecular Cancer Therapeutics 2009 / 04 Vol. 8; Iss. 4

The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects

Schwartz, D. L., Powis, G., Thitai-Kumar, A., He, Y., Bankson, J., Williams, R., Lemos, R., Oh, J., Volgin, A., Soghomonyan, S., Nishii, R., Alauddin, M., Mukhopadhay, U., Peng, Z., Bornmann, W., Gelo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-08-0981
Date:
April, 2009
File:
PDF, 1.26 MB
english, 2009
Conversion to is in progress
Conversion to is failed